| Description | In this talk, David will begin by introducing A-Alpha Bio, a drug discovery company that spun out of the University of Washington in 2018, with significant support from the UW ecosystem and CoMotion. He will also share the UW and Seattle resources they utilized to get the company started as well as lessons learned, for those considering starting or spinning out a company of their own.
David Younger is the co-founder and CEO of A-Alpha Bio, a Seattle-based biotechnology company using synthetic biology and machine learning to measure millions of protein-protein interactions and improve therapeutic discovery for antibodies and molecular glues. David invented A-Alpha Bio’s AlphaSeq platform with Scientific Advisors David Baker and Eric Klavins at the University of Washington, where he earned his PhD in Bioengineering. David's technical expertise spans synthetic biology, protein engineering, and Next Generation Sequencing assay development.
Format
Fundamentals for Startups is a weekly one-hour lecture series featuring notable experts who share startup-related information, experience, and insights with our entrepreneurial community. From raising capital to scaling to exit strategies, these seasoned guest speakers deliver valuable content designed to help startups and entrepreneurs thrive. Lectures are typically 30-40 mins, followed by open Q&A.Each lecture is filmed, live streamed and archived on CoMotion’s Startup Training Videos page. These lectures are open to the public and you do not have to be currently affiliated with the UW or a startup to join. Please register at the link above for access information. We hope you can join us online! |
|---|